Bluestone Talks About Tricky Balancing Act Between Academia and Industry
UCSF Executive Vice Chancellor and Provost Jeff Bluestone, PhD, gave a historical perspective on UCSF’s role in building the biotechnology industry and its ongoing efforts to speed up the process of translational medicine, in an interview with Luke Timmerman, national biotechnology editor for Xconomy. Excerpts from the interview were posted in a Q&A format on the Xconomy website and served as a preview of the mediagroup’s March 16 conference, Xconomy Forum: Bay Area Life Sciences, in which Bluestone is a a panelist.